Results 1-10 of approx. 153

Introgen Therapeutics Inc (INGN) Stock Quote

Get the latest INGN - Introgen Therapeutics Inc stock market performance data and financial news.

http://www.thestreet.com/quote/INGN.html

Jim Cramer's Take on Introgen Therapeutics Inc

Read Jim Cramer's take on Introgen Therapeutics Inc (INGN) and get his latest thoughts on the company?s performance and outlook

http://www.thestreet.com/cramerstake/INGN.html

Introgen Therapeutics Inc (INGN) Community Sentiment

Get the latest INGN - Introgen Therapeutics Inc together with stock market performance data and financial news.

http://www.thestreet.com/quote/INGN/details/sentiment.html

Introgen Therapeutics Inc (INGN) Stock Quote

Get the latest INGN - Introgen Therapeutics Inc stock market performance data and financial news.

http://www.thestreet.com/quote/INGN/real-time-news.html

Financial Portfolio on Recent Stock Quotes & Stock Market Picks ...

Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.

http://www.thestreet.com/earnings/INGN/

Introgen Critically Hurt by FDA Advexin Snub

By Adam Feuerstein 09/02/08

The regulator refused to accept an approval application for the gene therapy cancer drug, dealing a devastating blow to the company.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10435392/1/introgen-critically-hurt-by-fda-advexin-snub.html

Health Winners & Losers: Sciele Pharma

By Elizabeth Trotta 09/02/08

Shionogi & Co. plans to buy the remaining outstanding shares of Sciele Pharma for $31 a share.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10435487/1/health-winners-losers-sciele-pharma.html

Introgen's Data-Mining Misleads

By Adam Feuerstein 02/14/07

The company has tried to spin an underwhelming drug trial into a positive one.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/newsanalysis/biotech/10338486.html

Introgen's 'Promise'

By Adam Feuerstein 03/07/07

The approval timeline for its cancer gene therapy hasn't exactly remained stable.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10342959/1/introgens-promise.html

Thursday's Health Winners & Losers

By Elizabeth Trotta 09/06/07

Biogen Idec climbs on upbeat revenue guidance.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/newsanalysis/winnershealth/10378282.html

More From TheStreet

Latest Headlines

Brokerage Partners

TheStreet Premium Services

All Services